Measurement of cortical dopamine D1 receptor binding with [11C]SCH 23390:: A test-retest analysis

被引:24
作者
Hirvonen, J
Någren, T
Kajander, J
Hietala, J
机构
[1] Univ Turku, Dept Pharmacol & Clin Pharmacol, FIN-20520 Turku, Finland
[2] Univ Turku, Turku PET Ctr, FIN-20520 Turku, Finland
[3] Univ Turku, Cent Hosp, Dept Psychiat, FIN-20520 Turku, Finland
关键词
C-11]SCH 23390; dopamine D-1 receptors; positron emission tomography;
D O I
10.1097/00004647-200110000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[C-11]SCH 23390 is a standard ligand for positron emission tomography (PET) studies on striatal dopamine D-1 receptors. Its usefulness for cortical D-1 receptor quantification in human PET studies has been questioned but has not been addressed previously. The authors tested the reproducibility of [C-11]SCH 23390 binding potential (BP) in cortical areas in five healthy volunteers using three-dimensional PET. Measurement of D-1 receptor BP was reproducible in basal ganglia, as well as in all cortical areas studied (intraclass correlation coefficients between 0.81 and 0.92). The absolute variability in cortical areas was 9.21% +/- 0.07%. The reproducibility or cortical D-1 receptor BP measurement with [C-11]SCH 23390 is equal to that observed with a more recent D-1-ligand, [C-11]NNC 112. [C-11]NNC 112 produces slightly higher specific-to-nonspecific binding ratios but has markedly slower kinetics resulting in a need for a longer scan time. These aspects should be considered when designing studies on the cortical D-1-like receptors.
引用
收藏
页码:1146 / 1150
页数:5
相关论文
共 30 条
[1]   Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans:: Validation and reproducibility [J].
Abi-Dargham, A ;
Martinez, D ;
Mawlawi, O ;
Simpson, N ;
Hwang, DR ;
Slifstein, M ;
Anjilvel, S ;
Pidcock, J ;
Guo, NN ;
Lombardo, I ;
Mann, JJ ;
Van Heertum, R ;
Foged, C ;
Halldin, C ;
Laruelle, M .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (02) :225-243
[2]   NNC-112, NNC-687 AND NNC-756, NEW SELECTIVE AND HIGHLY POTENT DOPAMINE D1 RECEPTOR ANTAGONISTS [J].
ANDERSEN, PH ;
GRONVALD, FC ;
HOHLWEG, R ;
HANSEN, LB ;
GUDDAL, E ;
BRAESTRUP, C ;
NIELSEN, EB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 219 (01) :45-52
[3]   A FULLY-AUTOMATIC MULTIMODALITY IMAGE REGISTRATION ALGORITHM [J].
ARDEKANI, BA ;
BRAUN, M ;
HUTTON, BF ;
KANNO, I ;
IIDA, H .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1995, 19 (04) :615-623
[4]   A statistical method for the analysis of positron emission tomography neuroreceptor ligand data [J].
Aston, JAD ;
Gunn, RN ;
Worsley, KJ ;
Ma, Y ;
Evans, AC ;
Dagher, A .
NEUROIMAGE, 2000, 12 (03) :245-256
[5]   THE D-1 DOPAMINE RECEPTOR ANTAGONIST SCH 23390 ALSO INTERACTS POTENTLY WITH BRAIN-SEROTONIN (5-HT2) RECEPTORS [J].
BISCHOFF, S ;
HEINRICH, M ;
SONNTAG, JM ;
KRAUSS, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 129 (03) :367-370
[6]  
Chan GLY, 1998, J NUCL MED, V39, P792
[7]  
Chou YH, 1999, PSYCHOPHARMACOLOGY, V146, P220, DOI 10.1007/s002130051110
[8]   AUTORADIOGRAPHIC LOCALIZATION OF D1 AND D2 DOPAMINE-RECEPTORS IN THE HUMAN-BRAIN [J].
DEKEYSER, J ;
CLAEYS, A ;
DEBACKER, JP ;
EBINGER, G ;
ROELS, F ;
VAUQUELIN, G .
NEUROSCIENCE LETTERS, 1988, 91 (02) :142-147
[9]   PET ANALYSIS OF HUMAN DOPAMINE RECEPTOR SUBTYPES USING C-11 SCH 23390 AND C-11 RACLOPRIDE [J].
FARDE, L ;
HALLDIN, C ;
STONEELANDER, S ;
SEDVALL, G .
PSYCHOPHARMACOLOGY, 1987, 92 (03) :278-284
[10]   [11C]NNC 22-0215, a metabolically stable dopamine D1 radioligand for PET [J].
Foged, C ;
Halldin, C ;
Swahn, CG ;
Ginovart, N ;
Karlsson, P ;
Lundkvist, C ;
Farde, L .
NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (05) :503-508